Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Alexis Rossignol"'
1
A high-performance, non-radioactive potency assay for measuring cytotoxicity: A full substitute of the chromium-release assay targeting the regulatory-compliance objective
Autor: Alexis Rossignol, Henri Vié, Laurent Bretaudeau, Béatrice Clémenceau, Véronique Bonnaudet
Publikováno v: mAbs
mAbs, Taylor & Francis, 2017, 9 (3), pp.521-535. ⟨10.1080/19420862.2017.1286435⟩
mAbs, 2017, 9 (3), pp.521-535. ⟨10.1080/19420862.2017.1286435⟩
International audience; Standardized and biologically relevant potency assays are required by the regulatory authorities for the characterization and quality control of therapeutic antibodies. As critical mechanisms of action (MoA) of antibodies, the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::984d58e1b0287f7beabf04c96ca8399e
https://www.hal.inserm.fr/inserm-01806965
Zobrazit plný text záznamu
2
The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
Autor: Toufik Abache, Lucie Verhaeghe, Christine Gaucher, Thierry Chardès, André Pèlegrin, Aurélie Terrier, Alexandre Pichard, Isabelle Navarro-Teulon, Jean-Pierre Pouget, Alexandre Fontayne, Martine Pugnière, Pauline Estupina, Olivier Dubreuil, Marion Le Blay, Christophe De Romeuf, Alexis Rossignol, Jean-François Prost, Jean-Marc Barret, Maeva Chauvin, Emmanuel Deshayes, Nathalie Kersual, Marta Jarlier
Publikováno v: Oncotarget
Oncotarget, Impact journals, 2017, 8 (23), pp.37061-37079. ⟨10.18632/oncotarget.15715⟩
Oncotarget, 2017, 8 (23), pp.37061-37079. ⟨10.18632/oncotarget.15715⟩
International audience; Ovarian cancer is the leading cause of death in women with gynecological cancers and despite recent advances, new and more efficient therapies are crucially needed. Müllerian Inhibiting Substance type II Receptor (MISRII, als
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b1b86f7354f8e8843619cf60657d988
https://hal.umontpellier.fr/hal-02379710
Zobrazit plný text záznamu
3
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
Autor: Lydia Roy, Christine Giraud, Florence Jacomet, François Guilhot, André Herbelin, Alexis Rossignol, Aurélie Robin, Jean-Marc Gombert, Ali G. Turhan, Sara Basbous, Anaïs Levescot, Anne Barra
Publikováno v: European Journal of Immunology. 42:1870-1875
Chronic myeloid leukemia (CML) is a clonal hematopoietic stem-cell malignancy characterized by the presence of the chimeric BCR-ABL oncoprotein with deregulated tyrosine-kinase (TK) activity. Although conventional T cells are acknowledged as importan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e4182e279da30c8fdfdd6b965fcfb596
https://doi.org/10.1002/eji.201142043
Zobrazit plný text záznamu
5
The use of impression cytology in the follow-up of severe ocular burns
Autor: Martial Mercie, Jean-Jacques Gicquel, Renaud Navarre, Jean-Marc Gombert, Stephanie Balayre, Maria Elena Langman, Serge Milin, Alexis Rossignol, Pierre-Marie Levillain, Anne Barra, Alix Coulon, Paul Dighiero
Publikováno v: British Journal of Ophthalmology. 91:1160-1164
To evaluate by impression cytology (IC) the expression of the MHC class II inflammatory marker HLA-DR by the conjunctival epithelium, the cytological modifications of the conjunctival surface according to the Nelson's classification, and the eventual
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ff9d12a239c2f38daa61633939b5dbf
https://doi.org/10.1136/bjo.2007.114447
Zobrazit plný text záznamu
6
Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
Autor: Alexis, Rossignol, Anaïs, Levescot, Florence, Jacomet, Aurélie, Robin, Sara, Basbous, Christine, Giraud, Lydia, Roy, François, Guilhot, Ali G, Turhan, Anne, Barra, André, Herbelin, Jean-Marc, Gombert
Publikováno v: European journal of immunology. 42(7)
Chronic myeloid leukemia (CML) is a clonal hematopoietic stem-cell malignancy characterized by the presence of the chimeric BCR-ABL oncoprotein with deregulated tyrosine-kinase (TK) activity. Although conventional T cells are acknowledged as importan
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b05632873162591e598aac91311957aa
https://pubmed.ncbi.nlm.nih.gov/22585600
Zobrazit plný text záznamu
7
Evidence for a BCR-ABL-induced anergic state of iNTK cells in chronic myeloid leukemia patients at diagnosis (162.32)
Autor: Anais Levescot, Alexis Rossignol, Florence Jacomet, Aurélie Robin, Sara Basbous, Christine Giraud, Lydia Roy, François Guilhot, Ali Turhan, Anne Barra, André Herbelin, Jean-Marc Gombert
Publikováno v: The Journal of Immunology. 188:162.32-162.32
Chronic myeloid leukemia (CML) is a myeloproliferative disorder, caused by the presence of the Philadelphia chromosome and the consecutive chimerical BCR-ABL oncoprotein, with deregulated tyrosine kinase (TK) activity. Whether invariant NKT (iNKT) ce
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d001afa1dfd78e163bc055cab500eedf
https://doi.org/10.4049/jimmunol.188.supp.162.32
Zobrazit plný text záznamu
8
Depletion of Circulating Plasmacytoid Dendritic Cells in Chronic Myelogenous Leukemia and Their Restoration after Interferon-alpha or Imatinib Mesylate
Autor: Anne Barra, Lydia Roy, Jean-Marc Gombert, Alexis Rossignol, François Guilhot, Ali G. Turhan
Publikováno v: Blood. 108:2204-2204
It is currently established that the immune system plays a critical role in the control of chronic myelogenous leukemia (CML). Several cell populations including T cells, dendritic cells (DC) and NK cells have been shown to exhibit potential anti-leu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2ca4bcef2d34a5d4aef2d7a7afd29088
https://doi.org/10.1182/blood.v108.11.2204.2204
Zobrazit plný text záznamu
9
Functional Alterations of NKT Cells in Chronic Myeloid Leukemia Patients Can Be Reversed by Imatinib Mesylate In Vitro
Autor: Ali G. Turhan, Jean-Marc Gombert, François Guilhot, Anne Barra, Alexis Rossignol
Publikováno v: Blood. 108:2128-2128
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by the presence of the pathognomonic Philadelphia chromosome and the chimeric BCR-ABL oncoprotein with deregulated tyrosine kinase activity. It has been shown previously th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::baecaa9e4a6651d64fd6dff8d7e72d5e
https://doi.org/10.1182/blood.v108.11.2128.2128
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje